Blue Ledge Capital
Overview
Blue Ledge Capital is a venture capital investment firm that focuses on early-stage and growth investments in sectors including biotechnology, sustainable food production, and health technologies. The firm operates on a deal-by-deal basis, differentiating itself from traditional venture capital by not charging recurring management fees, instead using low, one-time syndication fees and a standard 20% performance fee. This model allows investors to choose investments on an individual basis. The firm's investment portfolio includes companies like AvantGuard, Qnovia, and Mission Barns.
Portfolio Companies
4
Website
blueledgecap.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Qnovia | Dec 2024 | Series B | Lead |
| Mission Barns | Apr 2021 | Series A | Co-investor |
| Entocycle | Jul 2024 | Series A Extension | Lead |
| AvantGuard | May 2023 | Seed | Lead |
Key People
Andy Roche
Founder and Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Blue Ledge Capital based?
Blue Ledge Capital is headquartered in Wilmington, Delaware, United States.
When was Blue Ledge Capital founded?
Founding year information for Blue Ledge Capital is not publicly available.
How many portfolio companies does Blue Ledge Capital have?
Blue Ledge Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Blue Ledge Capital's portfolio?
Portfolio companies visible on Caplight include Qnovia, Mission Barns, Entocycle, AvantGuard.
What was Blue Ledge Capital's most recent investment shown here?
Blue Ledge Capital's most recent investment in this portfolio sample was in Qnovia in 2024.
What sectors does Blue Ledge Capital focus on?
Blue Ledge Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does Blue Ledge Capital focus on?
Blue Ledge Capital typically invests at the Early stage.